-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Invivo Therapeutics Holdings Corp. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2011 to Q1 2023.
- Invivo Therapeutics Holdings Corp. Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $19K, a 46.2% increase year-over-year.
- Invivo Therapeutics Holdings Corp. annual Depreciation, Depletion and Amortization for 2022 was $60K, a 36.4% increase from 2021.
- Invivo Therapeutics Holdings Corp. annual Depreciation, Depletion and Amortization for 2021 was $44K, a 4.35% decline from 2020.
- Invivo Therapeutics Holdings Corp. annual Depreciation, Depletion and Amortization for 2020 was $46K, a 19.3% decline from 2019.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)